Beneficial Hypoglycemic, Hypolipidemic Effects of Aerial Branches and Roots Extract of Eryngium caeruleum M. Bieb on Streptozotocin-Induced Diabetes Model in Rats
Abstract
Eryngium caeruleum (Apiacea) is native to the northern forests of Iran. The anti-diabetic effect of other species of the genus Eryngium has already been reported in previous studies. In this study, the anti-diabetic effect of this extract on animal blood lipid factors was investigated. Hydroalcoholic extract was obtained from different parts of the plant, including roots, leaves, and aerial branches with fruits were prepared by maceration with 70% ethanol. Oral acute toxicity of the extracts was assayed in different doses of 2000, 4000, and 8000 mg/kg in rats. To induce diabetes in the studied animals, 60-70 mg/kg of streptozotocin (STZ) was injected intraperitoneally (IP). For the purpose of this study, 72 male Wistar rats were randomly divided into different groups of normal, diabetic, and positive controls (metformin 500 mg/kg) as well as 9 diabetic groups that orally received 200, 400, and 800 mg/kg of extracts. The effects of the treatment with extracts for a 14-day period were investigated on weight, blood glucose, and lipid profile. By comparing the control groups with the groups of hydroalcoholic extracts of E. caeruleum showed that the most effective sample on weight gain and also on reducing blood glucose was the group receiving 800 mg/kg of the aerial branches extract (P < 0.01 and P < 0.001, respectively) after 14 days. As well, the most effective sample on lowering the blood lipid factors was the hydroalcoholic extract of the root of E. coareleum with a dose of 200 mg/kg, which showed a significant effect on lowering total cholesterol in diabetic rats compared to the diabetic controls (P < 0.05). Hydroalcoholic extract of leaves with 200 mg/kg also showed a better effect on lowering the LDL and VLDL levels compared to the diabetic control group (P < 0.001). The results of pancreatic histology in the samples showed that the extracts of the aerial branch and root (800 mg/kg) had significant effects on the regeneration of the islets of Langerhans compared to the diabetic control group. In conclusion, E. caeruleum could significantly improve glycemic and lipid profiles in diabetic rats.
Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS medicine 2006;3:e442.
Kasper DLFA, Hauser S, Longo D. Harrison's Principles of Internal Medicine. 19th ed. McGraw-Hill Companies. New York 2015.
Xu L, Li Y, Dai Y, Peng J. Natural products for the treatment of type 2 diabetes mellitus: Pharmacology and mechanisms. Pharmacol Res 2018;130:451-465.
Ghajarieh Sepanlou M, Salami F, Mirabzadeh Ardakani M, Sadati Lamardi SN, Sadrai S et al. The proximate, mineral and amino acid composition of spring, autumn leaves and roots of Eryngium caeruleum M. Bieb. RJP 2019;6:1-7.
Sepanlou MG, Ardakani MM, Hajimahmoodi M, Sadrai S, Amin GR et al. Ethnobotanical and traditional uses, phytochemical constituents and biological activities of Eryngium species growing in Iran. TMR 2019;4:148.
Wang P, Su Z, Yuan W, Deng G, Li S. Phytochemical constituents and pharmacological activities of Eryngium L.(Apiaceae). Pharm Crops 2012;3:99.
Kikowska M, Dworacka M, Kędziora I, Thiem B. Eryngium creticum-ethnopharmacology, phytochemistry and pharmacological activity. A review. Revista Brasileira de Farmacognosia 2016;26:392-399.
Majidi Z, Sadati Lamardi SN, Mohajjel-Nayebi A, Vatankhah AM, Asnaashari S et al. Effects of Heracleum persicum hydroalcoholic extract on insulin, serum anti-oxidant enzymes, glucose, and lipid profiles in alloxan-induced diabetic rats. IJMS 2020;45:199-206.
Afshari M, Mohammadshahi M, Malayeri A, Zaheri L. Antidiabetic, Hepato-Protective and Hypolipidemic Effects of Eryngium caucasicum extract in streptozotocin-nicotinamide induced type 2 diabetes in male rats. Iraq Med J 2019;3:2521-8492.
Sadiq A, Rashid U, Ahmad S, Zahoor M, Al Ajmi MF et al. Treating Hyperglycemia From Eryngium caeruleum M. Bieb: in-vitro α-glucosidase, antioxidant, in-vivo antidiabetic and molecular docking-based approaches. Front Chem 2020;8:558641.
Jaghabir M. Hypoglycemic effects of Eryngium creticum. Arch Pharm Res 1991;14:295-297.
Noriega-Cisneros R, Ortiz-Avila O, Esquivel-Gutiérrez E, Clemente-Guerrero M, Manzo-Avalos S et al. Hypolipidemic activity of Eryngium carlinae on streptozotocin-induced diabetic rats. Biochem Res Int 2012;2012.
Norouzi M, Valipour Chahardah Charic S. The effect of Eryngium campestre hydroalcoholic extract on glucose and lipid indices of the blood in streptozotocin-induced diabetic male rats. JAR 2021. In Press.
Rehman AU, Hashmi MA, Tehseen Y, Khan A, Khan SS et al. Antidiabetic flavonol glycosides from Eryngium caeruleum. Rec Nat Prod 2017;11:229-234.
Dehghan H, Sarrafi Y, Salehi P. Antioxidant and antidiabetic activities of 11 herbal plants from Hyrcania region, Iran. JFDA 2016;24:179-188.
Kasabri V, Afifi FU, Hamdan I. Evaluation of the acute antihyperglycemic effects of four selected indigenous plants from Jordan used in traditional medicine. Pharm Biol 2011;49:687-695.
Bustanji Y, Issa A, Moulay A, Hudaib M, Tawaha K et al. Hormone sensitive lipase inhibition by selected medicinal plants. JMPR 2011;5:4405-4410.
Paul JH, Seaforth CE, Tikasingh T. Eryngium foetidum L.: A review. Fitoterapia 2011; 82:302-308.
Files | ||
Issue | Vol 6, No 2, 2021 | |
Section | Research Article(s) | |
DOI | https://doi.org/10.18502/tim.v6i2.6779 | |
Keywords | ||
Eryngium Diabetes mellitus Blood glucose Streptozotocin (STZ) Rats |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |